Need help finding what you are looking for?
Contact Us
PUBLISHER: BCC Research | PRODUCT CODE: 1642866
PUBLISHER: BCC Research | PRODUCT CODE: 1642866
High Content Screening/Imaging: Technologies and Global Markets
PUBLISHED:
PAGES: 141 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
The global market for high content screening and imaging (HCS/I) is estimated to increase from $3.4 billion in 2024 to reach $5.1 billion by 2029, at a compound annual growth rate (CAGR) of 8.4% from 2024 through 2029.
The North American market for HCS/I is estimated to increase from $1.2 billion in 2024 to reach $1.8 billion by 2029, at a CAGR of 7.1% from 2024 through 2029.
The Asia-Pacific market for HCS/I is estimated to increase from $886.7 million in 2024 to reach $1.4 billion by 2029, at a CAGR of 9.5% from 2024 through 2029.
Report Scope
The report offers a detailed picture of the high-content screening/imaging (HCS/I) market.
This report highlights the current and future market potential for HCS/I. It provides a detailed analysis of the competitive environment, regulatory scenario, drivers, restraints, opportunities and trends in the market. The report also covers market projections through 2029 and the market share of key players.
This report discusses the HCS/I industry and its resources. It covers the overall HCS/I market including instruments, consumables (reagents and kits), software and analytics, and services. The report further analyzes the market based on application, analyzing primary and secondary screening, target identification and validation, compound profiling, and toxicity studies. A complete regional analysis of the market is also offered in the report.
The market is segmented by region into North America, Europe, Asia-Pacific and the Rest of the World. Regional analysis is further broken down by country. North America is segmented into the U.S., Canada and Mexico; Europe is segmented into Germany, the U.K., France, Italy, Spain and the Rest of Europe; and Asia-Pacific is segmented into China, Japan, India, South Korea, Australia and the Rest of Asia-Pacific. For market estimates, data has been provided for 2021 and 2022 as the historic years, 2023 as the base year, and forecast for 2024 through 2029.
Report Includes
- 56 data tables and 57 additional tables
- Analyses of the trends in global market for high content screening/imaging (HCS/I) technologies, with market revenue data (sales figures) from 2021 and 2022, estimates for 2023, forecasts for 2024, and projected CAGRs through 2029
- Estimates of the market size and revenue growth prospects, along with a market share analysis by component, area of application, end user and region/country
- Facts and figures pertaining to key market dynamics, technological advances, regulations, and the impact of macroeconomic factors
- Insights derived from the Porter's Five Forces model, as well as global supply chain and PESTLE analyses
- An analysis of patents, emerging trends and developments
- A pricing analysis for HCS/I instruments from leading companies
- Analysis of the industry structure, including companies' market shares and rankings, strategic alliances, M&A activities, and a venture funding outlook
- Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, and the ESG scores and practices of leading companies
- Company profiles of major players within the industry, including Danaher Corp., Revvity, Thermo Fischer Scientific Inc., Agilent Technologies Inc., and Yokogawa Electric Corp.
Product Code: BIO166C
Table of Contents
Chapter 1 Executive Summary
- Market Outlook
- Scope of Report
- Market Insights
Chapter 2 Market Overview
- High-Content Screening Technology Overview
- High-Throughput Screening (HTS)
- Process Involved in High-Throughput Screening
- Developments in HTS
Chapter 3 Market Dynamics
- Overview
- Market Drivers
- Increasing R&D Budgets
- Technological Advances in HCS/I
- Market Restraints and Challenges
- High Equipment Costs
- Data Management Challenges
- Opportunities in the Market
- Opportunities in 3D Applications
- Emerging Economies
Chapter 4 Emerging Technologies and Developments
- Overview
- Emerging Technologies
- AI for High-Content Image Analysis
- Cell Painting
- 3D Organoid, Tumoroid and Spheroid Cultures
Chapter 5 Market Segment Analysis
- Segmentation Breakdown
- Market Analysis by Component
- Instruments
- Consumables
- Software and Analytics
- Services
- Market Analysis by Application
- Primary and Secondary Screening
- Target Identification and Validation
- Compound Profiling
- Toxicity Studies
- Other Applications
- Market Analysis by End User
- Pharmaceutical Companies
- Academics
- Laboratories and Pathology Centers
- Geographic Breakdown
- Market Analysis by Region
- North America
- Europe
- Asia-Pacific
- Rest of Asia-Pacific
- Rest of the World (RoW)
Chapter 6 Competitive Intelligence
- Company Share Analysis
- Strategic Analysis
- Partnerships
- Mergers and Acquisitions
- Product Launches
- Pricing Analysis
Chapter 7 Patent Review
- Patent Review
- Patent Review by Year
- Patent Review by Jurisdiction
- Patent Review by Top Applicants
- Selected Granted Patents
Chapter 8 Sustainability in the HCS/I Market: An ESG Perspective
- ESG Perspective
- Environmental Impact
- Social Impact
- Governance Impact
- Understanding the ESG Data
- ESG Performance Analysis
- Environmental Performance
- Social Performance
- Governance Performance
- Concluding Remarks from BCC
Chapter 9 Appendix
- Methodology
- Sources
- Abbreviations
- Company Profiles
- AGILENT TECHNOLOGIES INC.
- BD
- BIO-RAD LABORATORIES INC.
- BRUKER
- CHARLES RIVER LABORATORIES
- CORNING INC.
- DANAHER CORP.
- EVIDENT
- MERCK KGAA
- MILTENYI BIOTEC
- REVVITY
- SARTORIUS AG
- THERMO FISHER SCIENTIFIC INC.
- YOKOGAWA ELECTRIC CORP.
- ZEISS
Product Code: BIO166C
List of Tables
- Summary Table : Global Market for HCS/I, by Region, Through 2029
- Table 1 : HTS Detection Methods
- Table 2 : R&D Expenditure of Key Pharmaceutical Companies, 2023
- Table 3 : Global Market for HCS/I, by Component, Through 2029
- Table 4 : Global Market for HCS/I Instruments, by Region, Through 2029
- Table 5 : Global Market for HCS/I Instruments, by Type, Through 2029
- Table 6 : Selected Imaging Devices Available in the Market
- Table 7 : Global Market for Imaging Devices in HCS/I, by Region, Through 2029
- Table 8 : Selected Cytometers for Cellomics
- Table 9 : Global Market for HCS/I Cytometers, by Region, Through 2029
- Table 10 : Global Market for Plate Readers in HCS/I, by Region, Through 2029
- Table 11 : Global Market for Light Sources in HCS/I, by Region, Through 2029
- Table 12 : Global Market for Detectors and Sensors in HCS/I, by Region, Through 2029
- Table 13 : Global Market for Liquid Handling Instruments in HCS/I, by Region, Through 2029
- Table 14 : Global Market for HCS/I Consumables, by Region, Through 2029
- Table 15 : Global Market for HCS/I Software and Analytics, by Region, Through 2029
- Table 16 : Global Market for HCS/I Services, by Region, Through 2029
- Table 17 : Global Market for HCS/I, by Application, Through 2029
- Table 18 : Global Market for Primary and Secondary Screening Applications in HCS/I, by Region, Through 2029
- Table 19 : Global Market for Target Identification and Validation in HCS/I, by Region, Through 2029
- Table 20 : Global Market for Compound Profiling in HCS/I, by Region, Through 2029
- Table 21 : Toxicology Applications of HCS/I
- Table 22 : Global Market for HCS/I in Toxicity Studies, by Region, Through 2029
- Table 23 : Global Market for HCS/I in Other Applications, by Region, Through 2029
- Table 24 : Global Market for HCS/I, by End User, Through 2029
- Table 25 : Global HCS/I Market for Pharmaceutical Companies, by Region, Through 2029
- Table 26 : Global HCS/I Market for Academics, by Region, Through 2029
- Table 27 : Global HCS/I Market for Laboratories and Pathology Centers, by Region, Through 2029
- Table 28 : Global Market for HCS/I, by Region, Through 2029
- Table 29 : North American Market for HCS/I, by Country, Through 2029
- Table 30 : North American Market for HCS/I, by Component, Through 2029
- Table 31 : North American Market for HCS/I Instruments, by Type, Through 2029
- Table 32 : North American Market for HCS/I, by Application, Through 2029
- Table 33 : North American Market for HCS/I, by End User, Through 2029
- Table 34 : European Market for HCS/I, by Country, Through 2029
- Table 35 : European Market for HCS/I, by Component, Through 2029
- Table 36 : European Market for HCS/I Instruments, by Type, Through 2029
- Table 37 : European Market for HCS/I, by Application, Through 2029
- Table 38 : European Market for HCS/I, by End User, Through 2029
- Table 39 : Asia-Pacific Market for HCS/I, by Country, Through 2029
- Table 40 : Asia-Pacific Market for HCS/I, by Component, Through 2029
- Table 41 : Asia-Pacific Market for HCS/I Instruments, by Type, Through 2029
- Table 42 : Asia-Pacific Market for HCS/I, by Application, Through 2029
- Table 43 : Asia-Pacific Market for HCS/I, by End User, Through 2029
- Table 44 : RoW Market for HCS/I, by Component, Through 2029
- Table 45 : RoW Market for HCS/I Instruments, by Type, Through 2029
- Table 46 : RoW Market for HCS/I, by Application, Through 2029
- Table 47 : RoW Market for HCS/I, by End User, Through 2029
- Table 48 : Selected Strategic Alliances in the HCS/I Industry, 2023 and 2024
- Table 49 : Select M&A Activities in the AI in the Cancer Industry, 2024
- Table 50 : Product Launches in the HCS/I Industry, 2021-2024
- Table 51 : Average Selling Price of HCS/I Products
- Table 52 : Selected Patents Issued in HCS/I Industry, 2021-2024
- Table 53 : ESG Rankings for Major HCS/I Companies, as of September 2024
- Table 54 : ESG: Environmental Overview
- Table 55 : ESG: Social Overview
- Table 56 : ESG: Governance Overview
- Table 57 : Information Sources in this Report
- Table 58 : Abbreviations Used in the High Content Screening/Imaging Market
- Table 59 : Agilent Technologies Inc.: Company Snapshot
- Table 60 : Agilent Technologies Inc.: Financial Performance, FY 2022 and 2023
- Table 61 : Agilent Technologies Inc.: Product Portfolio
- Table 62 : Agilent Technologies Inc.: News/Key Developments, 2023
- Table 63 : BD: Company Snapshot
- Table 64 : BD: Financial Performance, FY 2022 and 2023
- Table 65 : BD: Product Portfolio
- Table 66 : BD: News/Key Developments, 2023
- Table 67 : Bio-Rad Laboratories Inc.: Company Snapshot
- Table 68 : Bio-Rad Laboratories Inc.: Financial Performance, FY 2022 and 2023
- Table 69 : Bio-Rad Laboratories Inc.: Product Portfolio
- Table 70 : Bruker: Company Snapshot
- Table 71 : Bruker: Financial Performance, FY 2022 and 2023
- Table 72 : Bruker: Product Portfolio
- Table 73 : Bruker: News/Key Developments, 2024
- Table 74 : Charles River Laboratories: Company Snapshot
- Table 75 : Charles River Laboratories: Financial Performance, FY 2022 and 2023
- Table 76 : Charles River Laboratories: Product Portfolio
- Table 77 : Corning Inc.: Company Snapshot
- Table 78 : Corning Inc.: Financial Performance, FY 2022 and 2023
- Table 79 : Corning Inc.: Product Portfolio
- Table 80 : Danaher Corp.: Company Snapshot
- Table 81 : Danaher Corp.: Financial Performance, FY 2022 and 2023
- Table 82 : Danaher Corp.: Product Portfolio
- Table 83 : Danaher Corp.: News/Key Developments, 2021-2024
- Table 84 : Evident: Company Snapshot
- Table 85 : Evident: Product Portfolio
- Table 86 : Evident: News/Key Developments, 2022 and 2023
- Table 87 : Merck KGaA: Company Snapshot
- Table 88 : Merck KGaA: Financial Performance, FY 2022 and 2023
- Table 89 : Merck KGaA: Product Portfolio
- Table 90 : Miltenyi Biotec: Company Snapshot
- Table 91 : Miltenyi Biotec: Product Portfolio
- Table 92 : Miltenyi Biotec: News/Key Developments, 2023 and 2024
- Table 93 : Revvity: Company Snapshot
- Table 94 : Revvity: Financial Performance, FY 2022 and 2023
- Table 95 : Revvity: Product Portfolio
- Table 96 : Revvity: News/Key Developments, 2023
- Table 97 : Sartorius AG: Company Snapshot
- Table 98 : Sartorius AG: Financial Performance, FY 2022 and 2023
- Table 99 : Sartorius AG: Product Portfolio
- Table 100 : Sartorius AG: News/Key Developments, 2023
- Table 101 : Thermo Fisher Scientific Inc.: Company Snapshot
- Table 102 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2022 and 2023
- Table 103 : Thermo Fisher Scientific Inc.: Product Portfolio
- Table 104 : Thermo Fisher Scientific Inc.: News/Key Developments, 2022 and 2023
- Table 105 : Yokogawa Electric Corp.: Company Snapshot
- Table 106 : Yokogawa Electric Corp.: Financial Performance, FY 2022 and 2023
- Table 107 : Yokogawa Electric Corp.: Product Portfolio
- Table 108 : Yokogawa Electric Corp.: News/Key Developments, 2024
- Table 109 : Zeiss: Company Snapshot
- Table 110 : Zeiss: Financial Performance, FY 2022 and 2023
- Table 111 : Zeiss: Product Portfolio
- Table 112 : Zeiss: News/Key Developments, 2023 and 2024
List of Figures
- Summary Figure : Shares of Global Market for HCS/I, by Region, 2023
- Figure 1 : HCS Applications
- Figure 2 : HCS in Drug Discovery
- Figure 3 : Methodology for Data Analysis in the HCS/I Market
- Figure 4 : Essential Tools for HCS
- Figure 5 : Advantages of HTS
- Figure 6 : Applications of High-Throughput Screening
- Figure 7 : Market Dynamics of HCS/I Technology
- Figure 8 : Technological Advances in HCS
- Figure 9 : Emerging Technologies in the HCS/I Market
- Figure 10 : Shares of Global Market for HCS/I, by Component, 2023
- Figure 11 : Global Market for HCS/I, by Region, 2021-2029
- Figure 12 : Global Market for HCS/I Instruments, 2021-2029
- Figure 13 : Shares of Global Market for HCS/I Instruments, by Type, 2023
- Figure 14 : Microplate Reader Categories
- Figure 15 : Global Market for HCS/I Consumables, 2021-2029
- Figure 16 : General Steps Involved in HCS/I Software Analysis
- Figure 17 : Global Market for HCS/I Software and Analytics, 2021-2029
- Figure 18 : Global Market for HCS/I Services, 2021-2029
- Figure 19 : Shares of Global Market for HCS/I, by Application, 2023
- Figure 20 : Features of a Lead Compound
- Figure 21 : Global Market for Primary and Secondary Screening Applications in HCS/I, 2021-2029
- Figure 22 : Global Market for Target Identification and Validation in HCS/I, 2021-2029
- Figure 23 : Strategies to Improve Screening Using Compound Profiling
- Figure 24 : Global Market for Compound Profiling in HCS/I, 2021-2029
- Figure 25 : Global Market for HCS/I in Toxicity Studies, 2021-2029
- Figure 26 : Global Market for HCS/I in Other Applications, 2021-2029
- Figure 27 : Global Market Shares of HCS/I, by End User, 2023
- Figure 28 : Global HCS/I Market for Pharmaceutical Companies, 2021-2029
- Figure 29 : Global HCS/I Market for Academics, 2021-2029
- Figure 30 : Global HCS/I Market for Laboratories and Pathology Centers, 2021-2029
- Figure 31 : Shares of Global Market for HCS/I, by Region, 2023
- Figure 32 : Global Market for HCS/I, by Region, 2021-2029
- Figure 33 : Shares of North American Market for HCS/I, by Country, 2023
- Figure 34 : U.S. Market for HCS/I, 2021-2029
- Figure 35 : Canadian Market for HCS/I, 2021-2029
- Figure 36 : Mexican Market for HCS/I, 2021-2029
- Figure 37 : European Market Shares of HCS/I, by Country, 2023
- Figure 38 : German Market for HCS/I, 2021-2029
- Figure 39 : French Market for HCS/I, 2021-2029
- Figure 40 : Italian Market for HCS/I, 2021-2029
- Figure 41 : Spanish Market for HCS/I, 2021-2029
- Figure 42 : U.K. Market for HCS/I, 2021-2029
- Figure 43 : Rest of European Market for HCS/I, 2021-2029
- Figure 44 : Shares of Asia-Pacific Market for HCS/I, by Country, 2023
- Figure 45 : Chinese Market for HCS/I, 2021-2029
- Figure 46 : Japanese Market for HCS/I, 2021-2029
- Figure 47 : Indian Market for HCS/I, 2021-2029
- Figure 48 : South Korean Market for HCS/I, 2021-2029
- Figure 49 : Australian Market for HCS/I, 2021-2029
- Figure 50 : Rest of Asia-Pacific Market for HCS/I, 2021-2029
- Figure 51 : Shares of Global Market for HCS/I, by Company, 2023
- Figure 52 : Strategies Adopted by Companies in the HCS/I Industry
- Figure 53 : Granted HCS/I Patents, by Year, 2021-2024
- Figure 54 : Granted HCS/I Patents, by Jurisdiction, 2021-2024
- Figure 55 : Top Applicants for Granted HCS/I Patents, 2021-2024
- Figure 56 : Agilent Technologies Inc.: Revenue Share, by Business Unit, FY 2023
- Figure 57 : Agilent Technologies Inc.: Revenue Share, by Country/Region, FY 2023
- Figure 58 : BD: Revenue Share, by Business Unit, FY 2023
- Figure 59 : BD: Revenue Share, by Country/Region, FY 2023
- Figure 60 : Bio-Rad Laboratories Inc.: Revenue Share, by Business Unit, FY 2023
- Figure 61 : Bio-Rad Laboratories Inc.: Revenue Share, by Country/Region, FY 2023
- Figure 62 : Bruker: Revenue Share, by Business Unit, FY 2023
- Figure 63 : Bruker: Revenue Share, by Country/Region, FY 2023
- Figure 64 : Charles River Laboratories: Revenue Share, by Business Unit, FY 2023
- Figure 65 : Charles River Laboratories: Revenue Share, by Country/Region, FY 2023
- Figure 66 : Corning Inc.: Revenue Share, by Business Unit, FY 2023
- Figure 67 : Corning Inc.: Revenue Share, by Country/Region, FY 2023
- Figure 68 : Danaher Corp.: Revenue Share, by Business Unit, FY 2023
- Figure 69 : Danaher Corp.: Revenue Share, by Country/Region, FY 2023
- Figure 70 : Merck KGaA: Revenue Share, by Business Unit, FY 2023
- Figure 71 : Merck KGaA: Revenue Share, by Country/Region, FY 2023
- Figure 72 : Revvity: Revenue Share, by Business Unit, FY 2023
- Figure 73 : Revvity: Revenue Share, by Country/Region, FY 2023
- Figure 74 : Sartorius AG: Revenue Share by Business Unit, FY 2023
- Figure 75 : Sartorius AG: Revenue Share, by Country/Region, FY 2023
- Figure 76 : Thermo Fisher Scientific Inc.: Revenue Share, by Business Unit, FY 2023
- Figure 77 : Thermo Fisher Scientific Inc.: Revenue Share, by Country/Region, FY 2023
- Figure 78 : Yokogawa Electric Corp.: Revenue Share, by Business Unit, FY 2023
- Figure 79 : Yokogawa Electric Corp.: Revenue Share, by Country/Region, FY 2023
- Figure 80 : Zeiss: Revenue Share, by Business Unit, FY 2023
- Figure 81 : Zeiss: Revenue Share, by Country/Region, FY 2023
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.